Metformin Works Through the Brain, Not Just the Body — 60 Years After Discovery, Here Is What Was Hidden

Scientists reveal metformin's blood sugar control actually works partly through the brain, not just the liver and muscles. This changes everything about how we understand the world's most prescribed diabetes drug.

Metformin has been prescribed to manage type 2 diabetes for approximately 60 years, making it one of the most widely used drugs in the history of medicine — an estimated 200 million people worldwide take it, and it is on the WHO's List of Essential Medicines. Doctors and patients have understood how it works: it reduces glucose production in the liver and improves insulin sensitivity in muscle and fat tissue. This understanding was correct, but a landmark paper published in late March 2026 reveals it was significantly incomplete.

The new research demonstrates that metformin also works through the brain — specifically, by switching off a protein called glucokinase regulatory protein (GKRP) in neurons in the hypothalamus, and activating a specific population of hypothalamic neurons that send signals to the liver telling it to reduce glucose output. This neurological pathway operates independently of the direct cellular effects on liver and muscle that were previously understood as metformin's complete mechanism of action.

The significance extends beyond scientific completeness. The brain pathway may explain why metformin works differently in different patients — why some experience substantial blood sugar control while others receive less benefit from equivalent doses. If the brain pathway's effectiveness varies by individual neurological characteristics that are independent of the liver and muscle responses, this could explain patient variability that has previously been attributed to undefined factors.

More significantly, the discovery opens new therapeutic possibilities. The hypothalamic neurons that metformin activates are part of circuits that control multiple aspects of metabolism beyond blood sugar — appetite regulation, energy expenditure, and fat storage among them. The specific neurological mechanism by which metformin activates these neurons may be targetable through more precise drug interventions that produce the metabolic benefits without the gastrointestinal side effects that make metformin intolerable for some patients.

For the tens of millions of people living with diabetes, this 60-year-old drug just became considerably more interesting scientifically.